merilog

Generic: insulin aspart-szjj

Labeler: sanofi-aventis u.s. llc
NDC Directory HUMAN PRESCRIPTION DRUG BLA Inactive Finished

Drug Facts

Product Profile

Brand Name merilog
Generic Name insulin aspart-szjj
Labeler sanofi-aventis u.s. llc
Dosage Form INJECTION, SOLUTION
Routes
INTRAVENOUS SUBCUTANEOUS
Active Ingredients

insulin aspart 100 [iU]/mL

Manufacturer
Sanofi-Aventis U.S. LLC

Identifiers & Regulatory

Product NDC 0024-5928
Product ID 0024-5928_cfcdd91c-ec57-416b-959e-0fd59030bcbb
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category BLA
Application Number BLA761325
Listing Expiration 2026-12-31
Marketing Start 2025-02-14

Pharmacologic Class

Established (EPC)
insulin analog [epc]
Chemical Structure
insulin [cs]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 00245928
Hyphenated Format 0024-5928

Supplemental Identifiers

RxCUI
2705733 2705739 2705741 2705745
UNII
D933668QVX
NUI
M0011417 N0000175453

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name merilog (source: ndc)
Generic Name insulin aspart-szjj (source: ndc)
Application Number BLA761325 (source: ndc)
Routes
INTRAVENOUS SUBCUTANEOUS
source: ndc

Resolved Composition

Strengths
  • 100 [iU]/mL
source: ndc
Packaging
  • 5 SYRINGE in 1 BOX (0024-5928-05) / 3 mL in 1 SYRINGE (0024-5928-00)
source: ndc

Packages (1)

0024-5928-05 5 SYRINGE in 1 BOX (0024-5928-05) / 3 mL in 1 SYRINGE (0024-5928-00)

Ingredients (1)

insulin aspart (100 [iU]/mL)

Linked Drug Pages (1)

MERILOG ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS", "SUBCUTANEOUS"], "spl_id": "cfcdd91c-ec57-416b-959e-0fd59030bcbb", "openfda": {"nui": ["M0011417", "N0000175453"], "unii": ["D933668QVX"], "rxcui": ["2705733", "2705739", "2705741", "2705745"], "spl_set_id": ["eee07a52-1102-4d48-9782-26061db175ad"], "pharm_class_cs": ["Insulin [CS]"], "pharm_class_epc": ["Insulin Analog [EPC]"], "manufacturer_name": ["Sanofi-Aventis U.S. LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "5 SYRINGE in 1 BOX (0024-5928-05)  / 3 mL in 1 SYRINGE (0024-5928-00)", "package_ndc": "0024-5928-05", "marketing_start_date": "20250214"}], "brand_name": "MERILOG", "product_id": "0024-5928_cfcdd91c-ec57-416b-959e-0fd59030bcbb", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Insulin Analog [EPC]", "Insulin [CS]"], "product_ndc": "0024-5928", "generic_name": "insulin aspart-szjj", "labeler_name": "Sanofi-Aventis U.S. LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "MERILOG", "active_ingredients": [{"name": "INSULIN ASPART", "strength": "100 [iU]/mL"}], "application_number": "BLA761325", "marketing_category": "BLA", "marketing_start_date": "20250214", "listing_expiration_date": "20261231"}